Bacterial Diseases
Bacterial Diseases(细菌性疾病)
Bacterial Diseases 相关产品(602)
- GC43626Erythromycin A N-oxideCAS: 992-65-4纯度: >98.00%
A potential impurity in commercial preparations of erythromycin
- GC43627Erythromycin lactobionateCAS: 3847-29-8纯度: >98.00%
Erythromycin lactobionate是红霉素的水溶性酯衍生物，属于大环内酯类抗生素。Erythromycin lactobionate具有广泛的抗菌谱，对肺炎链球菌、化脓性链球菌、金黄色葡萄球菌以及一些非典型病原体如肺炎支原体和肺炎衣原体等均有效。
- GC43675Florfenicol amine (hydrochloride)CAS: 108656-33-3纯度: >95.00%
A veterinary antibiotic metabolite
- GC43727Ganglioside GD1a mixture (sodium salt)CAS: 12707-58-3纯度: >98.00%
A mixture of ganglioside G D1a
- GC44050Leucinostatin ACAS: 76600-38-9纯度: >95.00%
A fungal metabolite with diverse biological activities
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC43588 | EGA | 415687-81-9 | >98.00% / >99.00% | |
An inhibitor of endosomal trafficking | ||||
| GC43612 | Enopeptin A | 139601-96-0 | >95.00% | |
A depsipeptide antibiotic | ||||
| GC43626 | Erythromycin A N-oxide | 992-65-4 | >98.00% | |
A potential impurity in commercial preparations of erythromycin | ||||
| GC43627 | Erythromycin lactobionate | 3847-29-8 | >98.00% | |
Erythromycin lactobionate是红霉素的水溶性酯衍生物，属于大环内酯类抗生素。Erythromycin lactobionate具有广泛的抗菌谱，对肺炎链球菌、化脓性链球菌、金黄色葡萄球菌以及一些非典型病原体如肺炎支原体和肺炎衣原体等均有效。 | ||||
| GC43645 | Extracellular Death Factor | 960129-66-2 | >95.00% | |
A quorum-sensing signal peptide | ||||
| GC43659 | Feglymycin | 209335-49-9 | >95.00% | |
A peptide with antibacterial and antiviral activities | ||||
| GC43665 | Finafloxacin (hydrochloride) | 209342-41-6 | >98.00% | |
A fluoroquinolone antibiotic | ||||
| GC43675 | Florfenicol amine (hydrochloride) | 108656-33-3 | >95.00% | |
A veterinary antibiotic metabolite | ||||
| GC43727 | Ganglioside GD1a mixture (sodium salt) | 12707-58-3 | >98.00% | |
A mixture of ganglioside G D1a | ||||
| GC43730 | Ganglioside GM1 Asialo Mixture | 71012-19-6 | >98.00% | |
A sphingolipid | ||||
| GC43731 | Ganglioside GM2 Asialo Mixture | 35960-33-9 | >98.00% | |
A sphingolipid | ||||
| GC43744 | Geninthiocin A | 158792-27-9 | >95.00% | |
A cyclic thiopeptide bacterial metabolite | ||||
| GC43755 | Gilvocarcin M | 77879-89-1 | >95.00% | |
An antibiotic | ||||
| GC43757 | Globotetraosylceramides (porcine RBC) | 11034-93-8 | >98.00% | |
A sphingolipid | ||||
| GC43824 | Hirsutide | 865368-30-5 | >95.00% | |
A cyclotetrapeptide fungal metabolite | ||||
| GC43883 | Hymeglusin | 29066-42-0 | >95.00% | |
An HMG-CoA synthase inhibitor | ||||
| GC44004 | Kijanimicin | 78798-08-0 | >99.00% | |
An broad spectrum antibiotic | ||||
| GC44020 | L-681,217 | - | >95.00% | |
An antibiotic | ||||
| GC44034 | Lariatin A | 732286-09-8 | >95.00% | |
An antimycobacterial peptide | ||||
| GC44050 | Leucinostatin A | 76600-38-9 | >95.00% | |
A fungal metabolite with diverse biological activities | ||||
| GC44051 | Leucomycin A13 | 78897-52-6 | >99.00% | |
A macrolide antibiotic | ||||
| GC44066 | Lincomycin | 154-21-2 | >98.00% | |
A lincosamide antibiotic | ||||
| GC44078 | LL-37 amide (trifluoroacetate salt) | - | >95.00% | |
An antimicrobial peptide | ||||
| GC44098 | Lydicamycin | 133352-27-9 | >95.00% | |
An antibiotic effective against MRSA | ||||